Yes, re-iterating my other post and adding to it:
6. Cellmid will begin to sign up Cancer Diagnostic Licenses, most likely with Pacific Edge, timing, imminent, probability, 100%
And a big tick for my number 5 prediction re cashflow with the likelihood of cashflow positive although it may happen sooner than I expected.
Headline from the announcement reads:
Pacific Edge (PEB) licensed Cellmids midkine diagnostic technology for use in their recently launched bladder cancer test
Revenues from the bladder cancer test are expected to commence in 2010
The terms include upfront and milestone payments and royalties
Too bad the market is in the doldrums.
- Forums
- ASX - By Stock
- AN1
- revenue coming in 2010
revenue coming in 2010, page-2
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AN1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.690M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
AN1 (ASX) Chart |
Day chart unavailable
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online